dihydrotestosterone has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattarai, A; Bobba, V; Geldenhuys, WJ; Lathia, JD; Li, Y; Orahoske, CM; Sabbagh, A; Salem, FM; Shukla, GC; Su, B; Wang, B; Zhang, W | 1 |
| Cong, P; Ding, Y; Jiang, Y; Wei, W; Wu, K; Xiang, L; Yu, X | 1 |
2 other study(ies) available for dihydrotestosterone and Glioblastoma
| Article | Year |
|---|---|
Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.
Topics: Androgen Antagonists; Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Drug Design; Gene Expression Regulation, Neoplastic; Glioblastoma; HSP27 Heat-Shock Proteins; Humans; Mice; Models, Molecular; Molecular Docking Simulation; Mutation; Proteasome Endopeptidase Complex; Receptors, Androgen; Small Molecule Libraries; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2021 |
Androgen receptor signaling regulates growth of glioblastoma multiforme in men.
Topics: Aged; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dihydrotestosterone; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Receptors, Androgen; Receptors, Transforming Growth Factor beta; Sex Characteristics; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1 | 2015 |